Probiotic Lactobacillus strains protect against myelosuppression and immunosuppression in cyclophosphamide-treated mice

International Immunopharmacology

Volumn 22, Issue 1, 2014, Pages 209-221

  Salva, Susana ^a,b   Marranzino, Gabriela ^a,b   Villena, Julio ^a,b   Agüero, Graciela ^a,c   Alvarez, Susana ^a,b,c  

^a Immunobiotics Research Group   (Argentina)

^b CENTRO DE REFERENCIA PARA LACTOBACILOS CERELA CONICET   (Argentina)

^c UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Cyclophosphamide; Immunobiotics; Immunosuppression; Lactobacillus casei CRL431; Lactobacillus rhamnosus CRL1506; Myelopoiesis

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; PROBIOTIC AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BONE MARROW SUPPRESSION; CANDIDA ALBICANS; CONTROLLED STUDY; GRANULOCYTE; IMMUNE DEFICIENCY; INFECTION RESISTANCE; INVASIVE CANDIDIASIS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MALE; MITOSIS; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; STEM CELL; STEM CELL MOBILIZATION; ANIMAL; CANDIDIASIS; CELL CULTURE; CELL MOTION; HEMATOPOIETIC STEM CELL; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; METABOLISM; MICROBIOLOGY; NEUTROPHIL;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS; CELL MOVEMENT; CELLS, CULTURED; CYCLOPHOSPHAMIDE; GRANULOCYTES; HEMATOPOIETIC STEM CELLS; IMMUNITY, INNATE; IMMUNOMODULATION; IMMUNOSUPPRESSION; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; MALE; MICE; MYELOID PROGENITOR CELLS; NEUTROPHILS; PHAGOCYTES; PROBIOTICS;

EID: 84904215910     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2014.06.017     Document Type: Article

References (55)

1. R.A. Brodsky High-dose cyclophosphamide for autoimmunity and alloimmunity Immunol Res 47 2010 179 184
2. P. Smolewski, M. Witkowska, and A. Korycka-Wołowiec New insights into biology, prognostic factors, and current therapeutic strategies in chronic lymphocytic leukemia ISRN Oncol 2013 2013 740615
3. A. Gozzetti, M. Defina, and A. Fabbri Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: Analysis of persistent and new-onset cytopenia Cancer 120 2014 451 452
4. M. Byrne, J.R. Wingard, and J.S. Moreb Continuous infusion cyclophosphamide and low-dose total body irradiation is a safe and effective conditioning regimen for autologous transplant in multiple myeloma Transplant Proc 45 2013 3361 3365
5. W. Dörffel, U. Rühl, H. Lüders, A. Claviez, M. Albrecht, and J. Bökkerink et al. Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: Final results of the multinational trial GPOH-HD95 J Clin Oncol 31 2013 1562 1568
6. K. Aoki, T. Takahashi, S. Tabata, M. Kurata, A. Matsushita, and K. Nagai et al. Efficacy and tolerability of reduced-dose 21-day cycle rituximab and cyclophosphamide, doxorubicin, vincristine and prednisolone therapy for elderly patients with diffuse large B-cell lymphoma Leuk Lymphoma 54 2013 2441 2447
7. A.E. Dezern, M.J. Styler, D.B. Drachman, L.K. Hummers, R.J. Jones, and R.A. Brodsky Repeated treatment with high dose cyclophosphamide for severe autoimmune diseases Am J Blood Res 3 2013 84 90
8. L. Luznik, and E.J. Fuchs High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation Immunol Res 47 2010 65 77
9. J.P. Kehrer, and S.S. Biswal The molecular effect of acrolein Toxicol Sci 57 2000 6 15
10. L. Guest, and J. Uetrecht Drugs toxic to the bone marrow that target stromal cells Immunopharmacol 46 2000 103 112 (Pubitemid 30019252)
11. G.J. Pass, D. Carrie, M. Boylan, S. Lorimore, E. Wright, and B. Houston et al. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: Studies with the hepatic cytochrome p450 reductase null mouse Cancer Res 65 2005 4211 4217 (Pubitemid 40775659)
12. M. Yankelevich, M.A. Goodell, and Kaplan Efficacy of delayed administration of post-chemotherapy granulocyte colony-stimulating factor: Evidence from murine studies of bone marrow cell kinetics Exp Hematol 36 2008 9 16 (Pubitemid 350266968)
13. M. Santosuosso, M. Divangahi, A. Zganlacz, and Z. Xing Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: Restoration by local granulocytes macrophage-colony-stimulating factor gene transfer Blood 99 2002 1246 1252 (Pubitemid 34547077)
14. S.E. Jang, E.H. Joh, H.Y. Lee, Y.T. Ahn, J.H. Lee, and C.S. Huh et al. Lactobacillus plantarum HY7712 ameliorates cyclophosphamide-induced immunosuppression in mice J Microbiol Biotechnol 23 2013 414 421
15. A.M. Buisman, T.L. Van Zwet, J.A. Langermans, M.F. Geertsma, P.J. Leenen, and R. van Furth Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice Immunol 97 1999 601 610 (Pubitemid 29356409)
16. S. Chandramathi, K. Suresh, Z.B. Anita, and U.R. Kuppusamy Infections of Blastocystis hominis and microsporidia in cancer patients: Are they opportunistic? Trans R Soc Trop Med Hyg 106 2012 267 269
17. G. Maschmeyer, A. Haas, and O.A. Cornely Invasive aspergillosis: Epidemiology, diagnosis and management in immunocompromised patients Drugs 67 2007 1567 1601 (Pubitemid 47267298)
18. P. Staber, S. Langner, H.J. Dornbusch, and P. Neumeister Antifungal management in cancer patients Wien Med Wochenschr 57 2007 503 510 (Pubitemid 350097772)
19. S. Wohlgemuth, G. Loh, and M. Blaut Recent developments and perspectives in the investigation of probiotic effects Int J Med Microbiol 300 2010 3 10
20. M. Popova, P. Molimard, S. Courau, J. Crociani, C. Dufour, and F. Le Vacon et al. Beneficial effects of probiotics in upper respiratory tract infections and their mechanical actions to antagonize pathogens J Appl Microbiol 113 2012 1305 1318
21. S. Salva, J. Villena, M. Herrera, and S. Alvarez Immunobiotic and hematopoyesis: Can immunobiotics beneficially modulate hemato-immune responses in immunocompromised hosts? H. Kitazawa, J. Villena, S. Alvarez, Probiotics: Immunobiotics and immunogenics 2013 Science Publishers, CRC Press, Taylor & Francis Group company Enfield New Hampshire, USA 280 297
22. J. Villena, S. Racedo, Bru E. Agüero, M. Medina, and S. Alvarez Lactobacillus casei improves resistance to pneumococcal respiratory infection in malnourished mice J Nutr 135 2005 1462 1469 (Pubitemid 40799611)
23. S. Salva, J. Villena, R. Racedo, G. Agüero, and S. Alvarez Lactobacillus casei addition to a repletion diet induced early normalization of cytokine profiles during pneumococcal infection in malnourished mice Food Agric Immunol 19 2008 195 211
24. S. Salva, M. Nuñez, J. Villena, A. Ramón, G. Font, and S. Alvarez Development of a probiotic fermented goat milk containing Lactobacillus rhamnosus. In vivo study of health benefits J Sci Food Agric 91 2011 2355 2362
25. J. Villena, N.P. Barbieri, S. Salva, M. Herrera, and S. Alvarez Nasal treatment with Lactobacillus casei enhances immunty against pneumococcal challenge in malnourished mice Microbiol Immunol 53 2009 636 646
26. S. Salva, M.C. Merino, G. Agüero, A. Gruppi, and S. Alvarez Dietary supplementation with probiotics improves hematopoiesis in malnourished mice PLoS ONE 7 2012 e31171
27. S. Racedo, J. Villena, M. Medina, G. Agüero, V. Rodríguez, and S. Alvarez Lactobacillus casei administration reduces lung injuries in a Streptococcus pneumoniae infection Microbes Infect 8 2006 2359 2366 (Pubitemid 44499044)
28. S. Salva, J. Villena, and S. Alvarez Immunomodulatory activity of Lactobacillus rhamnosus strains isolated from goat milk: Impact on intestinal and respiratory infections Int J Food Microbiol 141 2010 82 89
29. J. Villena, S. Salva, G. Agüero, and S. Alvarez Immunomodulatory and protective effect of probiotic Lactobacillus casei against Candida albicans infection in malnourished mice Microbiol Immunol 55 2011 434 445
30. G. Marranzino, J. Villena, S. Salva, and S. Alvarez Stimulation of macrophages by immunobiotic Lactobacillus strains: Influence beyond the intestinal tract Microbiol Immunol 56 2012 771 781
31. M. Herrera, S. Salva, J. Villena, N. Barbieri, and S. Alvarez Lactobacillus rhamnosus CRL1505 enhances systemic and respiratory innate immune response in immunocompromised malnourished mice J Funct Foods 5 2013 1693 1704
32. T. Nagasawa Microenvironmental niches in the bone marrow required for B-cell development Nat Rev Immunol 6 2006 107 116 (Pubitemid 43361586)
33. U. Emmenegger, S. Man, Y. Shaked, G. Francia, J.W. Wong, and D.J. Hicklin et al. Comparative analysis of low-dose metronomic cyclophosphamide reveals absent or low-grade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens Cancer Res 64 2004 3994 4000 (Pubitemid 38697315)
34. P. Szumilas, K. Barcew, M. Baskiewicz-Masiuk, B. Wiszniewska, M.Z. Ratajczak, and B. Machaliński Effect of stem cell mobilization with cyclophosphamides plus colony-stimulating factor on morphology of haematopietic organs in mice Cell Prolif 38 2005 47 61 (Pubitemid 40229267)
35. A.F. Zuluaga, B.E. Salazar, C.A. Rodriguez, A.X. Zapata, M. Agudelo, and O. Vesga Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: Characterization and applicability to diverse experimental models of infectious diseases BMC Infect Dis 6 2006 55
36. H. Wang, M. Wang, J. Chen, Y. Tang, J. Dou, and J. Yu et al. A polysaccharide from Strongylocentrotus nudus eggs protects against myelosuppression and immunosuppression in cyclophosphamide-treated mice Int Immunopharmacol 11 2011 1946 1953
37. S.E. Jang, E.H. Joh, Y.T. Ahn, C.S. Huh, M.J. Han, and D.H. Kim Lactobacillus casei HY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic t cells and macrophages Immunopharmacol Immunotoxicol 35 2013 396 402
38. X.L. Zhu, J.H. Liu, W.D. Li, and Z.B. Lin Promotion of myelopoiesis in myelosuppressed mice by Ganoderma lucidum polysaccharides Front Pharmacol 3 2012 1 10
39. C. Bujalance, E. Moreno, M. Jimenez-Valera, and A. Ruiz-Bravo A probiotic strain of Lactobacillus plantarum stimulates lymphocyte responses in immunologically intact and immunocompromised mice Int J Food Microbiol 113 2007 28 34 (Pubitemid 44918150)
40. Lis M. Obmińska-Mrukowicz Effects of bestatin on phagocytic cells in cyclophosphamide-treated mice Pharmacol Rep 63 2011 1481 1490
41. S. Ahmad, D. Mika, and C. Guruvayoorappan Chemoprotective and immunomodulatory effect of Acacia nilotica during cyclophosphamide induced toxicity J Exp Ther Oncol 10 2012 83 90
42. J. Wang, X. Tong, P. Li, H. Cao, and W. Su Immuno-enhancement effects of Shenqi Fuzheng injection on cyclophosphamide-induced immunosuppression in Balb/c mice J Ethnopharmacol 139 2012 788 795
43. Y. Fan, Y. Lu, D. Wang, J. Liu, X. Song, and W. Zhang et al. Effect of epimedium polysaccharide-propolis flavone immunopotentiator on immunosuppression induced by cyclophosphamide in chickens Cell Immunol 281 2013 37 43
44. A. Hussain, W. Shadma, A. Maksood, and S.H. Ansari Protective effects of Picrorhiza kurroa on cyclophosphamide-induced immunosuppression in mice Pharmacogn Res 5 2013 30 35
45. U. Harnack, K. Eckert, I. Fichtner, and G. Pecher Comparison of the effect of orally administered soluble beta-(1-3), (1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis In Vivo 24 2010 59 63
46. X. Chen, W. Nie, S. Fan, J. Zhang, Y. Wang, and J. Lu et al. A polysaccharide from Sargassum fusiforme protects against immunosuppression in cyclophosphamide-treated mice Carbohydr Polym 90 2012 1114 1119
47. Y. Guo, D. Pan, H. Li, Y. Sun, X. Zeng, and B. Yan Antioxidant and immunomodulatory activity of selenium exopolysaccharide produced by Lactococcus lactis subsp Lactis Food Chem. 138 2013 84 89
48. G.P. Rosen, K. Nielsen, S. Glenn, J. Abelson, J. Deville, and T.B. Moore Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution J Pediatr Hematol Oncol 27 2005 135 140 (Pubitemid 40397242)
49. A.Y. Koh, J.R. Köhler, K.T. Coggshall, N. Van Rooijen, and G.B. Pier Mucosal damage and neutropenia are required for Candida albicans dissemination PLoS Pathog 4 2008 e35
50. D.C. Link Neutrophil homeostasis: A new role for stromal cell-derived factor-1 Immunol Res 32 2005 169 178 (Pubitemid 41153621)
51. C. Martin, P.C. Burdon, G. Bridger, J.C. Gutierrez-Ramos, T.J. Williams, and S.M. Rankin Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence Immun 9 2003 583 593 (Pubitemid 37311439)
52. H.K. Kim, Sierra M. De La Luz, C.K. Williams, A.V. Gulino, and G. Tosato G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells Blood 108 2006 812 820 (Pubitemid 44154612)
53. H. Herrera, S. Salva, J. Villena, N. Barbieri, G. Marrazino, and S. Alvarez Dietary supplementation with lactobacilli improves emergency granulopoiesis in protein-malnourished mice and enhances respiratory innate immune response PLoS ONE 9 2014 e90227
54. T.B. Clarke, K.M. Davis, E.S. Lysenko, A.Y. Zhou, Y. Yu, and J.N. Weiser Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity Nat Med 16 2010 228 231
55. A. Trompette, E.S. Gollwitzer, K. Yadava, A.K. Sichelstiel, N. Sprenger, and C. Ngom-Bru et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis Nat Med 20 2014 159 166